Trinity Biotech plc Company Profile (NASDAQ:TRIB)

About Trinity Biotech plc

Trinity Biotech plc logoTrinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TRIB
  • CUSIP:
Key Metrics:
  • Previous Close: $6.23
  • 50 Day Moving Average: $6.56
  • 200 Day Moving Average: $8.45
  • 52-Week Range: $22,797,000.00 - $5.76
  • Trailing P/E Ratio: 47.52
  • Foreward P/E Ratio: 15.80
  • P/E Growth: -0.17
  • Market Cap: $144.08M
  • Outstanding Shares: 22,797,000
  • Beta: 1.17
Profitability:
  • Net Margins: 3.04%
  • Return on Equity: 2.73%
  • Return on Assets: 1.60%
Debt:
  • Debt-to-Equity Ratio: 0.48%
  • Current Ratio: 7.27%
  • Quick Ratio: 5.35%
Additional Links:
Companies Related to Trinity Biotech plc:

Analyst Ratings

Consensus Ratings for Trinity Biotech plc (NASDAQ:TRIB) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: N/A

Analysts' Ratings History for Trinity Biotech plc (NASDAQ:TRIB)
Show:
DateFirmActionRatingPrice TargetDetails
10/5/2016StephensDowngradeOverweight -> Equal WeightView Rating Details
4/21/2016Roth CapitalReiterated RatingBuyView Rating Details
10/23/2015Craig HallumDowngradeBuy -> Hold$24.00 -> $14.00View Rating Details
9/3/2015Raymond James Financial, Inc.Initiated CoverageOutperform$20.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Trinity Biotech plc (NASDAQ:TRIB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/1/2017        
10/25/2016Q3$0.07$0.07$26.50 million$26.10 millionViewListenView Earnings Details
7/21/2016Q2$0.06$0.09$24.30 million$26.30 millionViewListenView Earnings Details
4/19/2016Q1$0.08$0.06ViewListenView Earnings Details
3/3/2016Q4$0.09$0.29$251.00 million$271.20 millionViewN/AView Earnings Details
10/22/2015Q3$0.09$0.10$25.40 million$27.20 millionViewListenView Earnings Details
7/28/2015Q2$0.14$0.07ViewListenView Earnings Details
4/30/2015Q115$0.17$0.17$25.93 million$25.20 millionViewN/AView Earnings Details
3/3/2015Q414$0.18$0.18$27.30 million$26.70 millionViewN/AView Earnings Details
10/23/2014Q114$0.20$0.19$27.30 million$27.20 millionViewListenView Earnings Details
7/29/2014Q413$0.20$0.18$27.00 million$26.00 millionViewN/AView Earnings Details
4/29/2014$0.19$0.18ViewN/AView Earnings Details
3/4/2014Q4$0.21$0.20ViewN/AView Earnings Details
10/17/2013Q313$0.21$0.21$24.68 million$24.10 millionViewN/AView Earnings Details
7/30/2013Q2 2013$0.20$0.21$22.03 million$21.30 millionViewN/AView Earnings Details
3/5/2013Q4 2012$0.21$0.20$21.84 million$20.80 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Trinity Biotech plc (NASDAQ:TRIB)
Current Year EPS Consensus Estimate: $-2.55 EPS
Next Year EPS Consensus Estimate: $0.40 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.08$0.08$0.08
Q2 20162$0.05$0.07$0.06
Q3 20162$0.06$0.07$0.07
Q4 20162$0.06$0.07$0.07
Q1 20171$0.04$0.04$0.04
Q2 20171$0.06$0.06$0.06
Q3 20171$0.08$0.08$0.08
Q4 20171$0.08$0.08$0.08
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Trinity Biotech plc (NASDAQ:TRIB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/23/2014annual$0.223.72%6/6/20146/10/20147/1/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Trinity Biotech plc (NASDAQ:TRIB)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Trinity Biotech plc (NASDAQ:TRIB)
DateHeadline
4-traders.com logoTrinity Biotech : to Announce Q4 and FY 2016 Results (NASDAQ:TRIB)
www.4-traders.com - February 24 at 11:03 AM
finance.yahoo.com logoTrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results (NASDAQ:TRIB)
finance.yahoo.com - February 24 at 11:03 AM
feeds.benzinga.com logoTrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results (NASDAQ:TRIB)
feeds.benzinga.com - February 24 at 8:13 AM
News IconIs The Sell-Side Predicting That Trinity Biotech plc (NASDAQ:TRIB) Will Move Higher? - Winfield Review (NASDAQ:TRIB)
winfieldreview.com - February 17 at 6:57 PM
News IconTrinity Biotech Plc (NASDAQ:TRIB) Analyst Coverage - NewsDen (NASDAQ:TRIB)
newsden.net - February 17 at 6:57 PM
realistinvestor.com logoTrinity Biotech plc (NASDAQ:TRIB) Is Expected To Post EPS Of $0.11 - RealistInvestor.com (NASDAQ:TRIB)
www.realistinvestor.com - February 13 at 1:14 AM
News IconStock Watch: Viewing the Numbers for Trinity Biotech plc (TRIB) - Sherwood Daily (NASDAQ:TRIB)
sherwooddaily.com - February 11 at 5:45 AM
News IconTrading Sheet: Tracking Technicals for Trinity Biotech plc (TRIB) - Sherwood Daily (NASDAQ:TRIB)
sherwooddaily.com - February 4 at 5:26 AM
News IconInside Track: Trading Focus on Shares of Trinity Biotech plc (TRIB) - Sherwood Daily (NASDAQ:TRIB)
sherwooddaily.com - February 2 at 6:10 AM
sbwire.com logoEurope in Vitro Diagnostic Device (IVD) Companies Market Research Report: The Top 200 IVD Companies in Europe; New Report Launched (NASDAQ:TRIB)
www.sbwire.com - January 31 at 5:40 AM
News IconChecking in on Signals for Trinity Biotech plc (TRIB) - Sherwood Daily (NASDAQ:TRIB)
sherwooddaily.com - January 28 at 7:07 AM
News IconWith Markets Booming Higher, Is This Stock Fairly Valued: Trinity Biotech plc (NASDAQ:TRIB) - Aiken Advocate (NASDAQ:TRIB)
aikenadvocate.com - January 27 at 6:19 AM
News IconEarnings in Full Force, Analysts Take Aim at Trinity Biotech plc (NASDAQ:TRIB) - Wall Street Beacon (NASDAQ:TRIB)
wsbeacon.com - January 27 at 6:19 AM
News IconDoes This Dividend Rockstar Have Potential Upside? Analysts Weigh in on Trinity Biotech plc (NASDAQ:TRIB) - Aiken Advocate (NASDAQ:TRIB)
aikenadvocate.com - January 25 at 7:39 AM
News IconWhat are Research Firms Saying About Trinity Biotech plc (NASDAQ:TRIB)? - Aiken Advocate (NASDAQ:TRIB)
aikenadvocate.com - January 25 at 7:39 AM
News IconPoint-of-care Diagnostics Market is Expected to Reach US$ 11.7 Billion by 2024 (NASDAQ:TRIB)
reports.pr-inside.com - January 24 at 8:54 AM
marketwatch.com logoImmunoassay Markets: Global Analysis and Opportunity Evaluation 2016 - 2020 (NASDAQ:TRIB)
www.marketwatch.com - January 24 at 12:17 AM
News IconLaboratory Based Analysis Of Global Blood Testing Market During The Forecast Period 2017 – 2020 (NASDAQ:TRIB)
www.medgadget.com - January 21 at 4:02 AM
News IconDividend Darling With Consensus Upside? Look No Further Than Trinity Biotech plc (NASDAQ:TRIB) - Aiken Advocate (NASDAQ:TRIB)
aikenadvocate.com - January 17 at 10:35 AM
News IconSell-side is Weighing in on Trinity Biotech plc (NASDAQ:TRIB) Earnings & Targets - Aiken Advocate (NASDAQ:TRIB)
aikenadvocate.com - January 17 at 10:35 AM
finance.yahoo.com logoThe Top 200 IVD Companies In Europe (NASDAQ:TRIB)
finance.yahoo.com - January 16 at 8:05 PM
News IconWill The Needle Move For Trinity Biotech plc (NASDAQ:TRIB) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:TRIB)
wsbeacon.com - January 15 at 2:20 AM
News IconMarkets End Mostly Higher, How Did This Stock Fare: Trinity Biotech plc (NASDAQ:TRIB) - Wall Street Beacon (NASDAQ:TRIB)
wsbeacon.com - January 15 at 2:19 AM
businesswire.com logoBragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages ... - Business Wire (press release) (NASDAQ:TRIB)
www.businesswire.com - January 7 at 6:07 AM
finance.yahoo.com logoBragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages Investors to Contact the Firm (NASDAQ:TRIB)
finance.yahoo.com - January 6 at 6:15 AM
News IconTrinity Biotech Plc (NASDAQ:TRIB) Valuation According To Analysts - UK Market News (NASDAQ:TRIB)
www.ukmarketnews.co.uk - December 28 at 8:46 AM
News IconGlobal POC Glycated Hemoglobin Analyzer Sales Market 2016 - Convergent Technologies, Infopia, Roche, Trinity Biotech plc (NASDAQ:TRIB)
www.mynewsdesk.com - December 22 at 5:07 AM
streetinsider.com logoForm 6-K TRINITY BIOTECH PLC For: Dec 01 (NASDAQ:TRIB)
www.streetinsider.com - December 19 at 8:54 AM
insidermonkey.com logoIs Trinity Biotech plc (ADR) (TRIB) A Good Stock To Buy? - Insider Monkey (blog) (NASDAQ:TRIB)
www.insidermonkey.com - December 9 at 8:18 PM
insidermonkey.com logoIs American Public Education, Inc. (APEI) a Good Stock to Buy? (NASDAQ:TRIB)
www.insidermonkey.com - December 9 at 8:18 PM
News IconIs Trinity Biotech plc (ADR) (TRIB) A Good Stock To Buy? (NASDAQ:TRIB)
feedproxy.google.com - December 8 at 5:28 PM
News IconCan This Stock Build Some Momentum: Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - December 6 at 8:18 AM
News IconWhat are the Levels Showing for Shares of Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - December 1 at 8:11 PM
News IconTrading Watch: Indicators in Review for Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - November 27 at 1:49 PM
News IconTrinity Biotech Plc Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 (NASDAQ:TRIB)
www.bioportfolio.com - November 24 at 7:53 PM
News IconDoes This Dividend Diamond Have Upside According to the Street: Trinity Biotech plc (NASDAQ:TRIB) - CSZ News (NASDAQ:TRIB)
cincysportszone.com - November 22 at 12:44 PM
News IconAnalysts Take: Trinity Biotech plc (NASDAQ:TRIB) Projected Earnings & Price Targets - CSZ News (NASDAQ:TRIB)
cincysportszone.com - November 21 at 8:31 PM
realistinvestor.com logoTrinity Biotech plc (NASDAQ:TRIB) Projected EPS At $0.11 - RealistInvestor.com (NASDAQ:TRIB)
www.realistinvestor.com - November 21 at 8:31 PM
News IconInvestor Arena: Keeping an Eye on Trinity Biotech plc (TRIB) - MicroCap Wired (NASDAQ:TRIB)
www.microcapwired.com - November 21 at 8:31 PM
News IconTrading Focus: Checking ATR Levels for Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - November 21 at 9:17 AM
News IconTechnical Update on Shares of Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - November 19 at 10:25 AM
News IconTrinity Biotech Plc TRIB Financial and Strategic SWOT Analysis Review Prices from USD $125 (NASDAQ:TRIB)
www.bioportfolio.com - November 18 at 7:35 PM
News IconRSI Review on Shares of Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - November 16 at 8:14 PM
News IconTrading Watch: ADX and CCI Review for Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - November 11 at 7:46 PM
News IconInvestor Sphere: Keeping an Eye on Levels for Trinity Biotech plc (TRIB) - MicroCap Wired (NASDAQ:TRIB)
www.microcapwired.com - November 10 at 7:59 PM
News IconRSI Update on Shares of Trinity Biotech plc (TRIB) - Yankee Analysts (NASDAQ:TRIB)
yankeeanalysts.com - November 9 at 8:02 PM
News IconTechnical Focus: What's Happening With Shares of Trinity Biotech plc (TRIB) - MicroCap Wired (NASDAQ:TRIB)
www.microcapwired.com - November 7 at 8:56 PM
realistinvestor.com logoEPS Of $0.11 Predicted For Trinity Biotech plc (NASDAQ:TRIB) - RealistInvestor.com (NASDAQ:TRIB)
www.realistinvestor.com - November 7 at 12:09 PM
News IconLooking Ahead for Trinity Biotech plc (NASDAQ:TRIB); Are These Shares Ready to Go Higher? - CSZ News (NASDAQ:TRIB)
cincysportszone.com - November 7 at 12:09 PM
News IconIndicator Review on Shares of Trinity Biotech plc (TRIB) - MicroCap Wired (NASDAQ:TRIB)
www.microcapwired.com - November 2 at 8:27 PM

Social

What is Trinity Biotech plc's stock symbol?

Trinity Biotech plc trades on the NASDAQ under the ticker symbol "TRIB."

When will Trinity Biotech plc announce their earnings?

Trinity Biotech plc is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.

Who owns Trinity Biotech plc stock?

Trinity Biotech plc's stock is owned by many different of institutional and retail investors. Top institutional investors include Janus Capital Management LLC (6.23%), First Wilshire Securities Management Inc. (3.88%), Stonehill Capital Management LLC (3.24%), Stonepine Capital Management LLC (1.91%), Russell Investments Group Ltd. (1.83%) and Hunter Associates Investment Management LLC (1.83%).

Who sold Trinity Biotech plc stock? Who is selling Trinity Biotech plc stock?

Trinity Biotech plc's stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, Renaissance Technologies LLC and Janus Capital Management LLC.

Who bought Trinity Biotech plc stock? Who is buying Trinity Biotech plc stock?

Trinity Biotech plc's stock was purchased by a variety of institutional investors in the last quarter, including First Wilshire Securities Management Inc., Stonehill Capital Management LLC, Stonepine Capital Management LLC, Russell Investments Group Ltd., Two Sigma Investments LP, ARS Investment Partners LLC, Oxford Asset Management and Hunter Associates Investment Management LLC.

How do I buy Trinity Biotech plc stock?

Shares of Trinity Biotech plc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Trinity Biotech plc stock cost?

One share of Trinity Biotech plc stock can currently be purchased for approximately $6.32.

Trinity Biotech plc (NASDAQ:TRIB) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Trinity Biotech plc (NASDAQ:TRIB)

Earnings History Chart

Earnings by Quarter for Trinity Biotech plc (NASDAQ:TRIB)

Dividend History Chart

Dividend Payments by Quarter for Trinity Biotech plc (NASDAQ:TRIB)

Last Updated on 2/27/2017 by MarketBeat.com Staff